AstraZeneca Introduces Direct-to-Consumer Platform to Enhance Medication Access for US Patients, Including Those with Chronic Conditions
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 26 2025
0mins
Source: Newsfilter
Launch of AstraZeneca Direct: AstraZeneca has introduced AstraZeneca Direct, an online platform for eligible patients to access prescribed medications at a cash price with home delivery, starting October 1, 2025. This service will support patients with chronic conditions and provide significant discounts on medications like AIRSUPRA and FARXIGA.
Commitment to Accessibility: The initiative aims to enhance accessibility and affordability in healthcare, complementing existing patient support services, and ensuring patients receive necessary medications conveniently and transparently.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
